Literature DB >> 24825851

Prognostic potential of DNA methylation and transcript levels of HIF1A and EPAS1 in colorectal cancer.

Agnieszka Anna Rawłuszko-Wieczorek1, Karolina Horbacka2, Piotr Krokowicz2, Matthew Misztal3, Paweł Piotr Jagodziński3.   

Abstract

UNLABELLED: Hypoxic conditions during the formation of colorectal cancer may support the development of more aggressive tumors. Hypoxia-inducible factor (HIF) is a heterodimeric complex, composed of oxygen-induced HIFα and constitutively expressed HIFβ subunits, which mediates the primary transcriptional response to hypoxic stress. Among HIFα isoforms, HIF1α (HIF1A) and endothelial PAS domain-containing protein 1 (EPAS1) are able to robustly activate hypoxia-responsive gene signatures. Although posttranslational regulation of HIFα subunits is well described, less is known about their transcriptional regulation. Here, molecular analysis determined that EPAS1 mRNA was significantly reduced in primary colonic adenocarcinoma specimens compared with histopathologically nonneoplastic tissue from 120 patients. In contrast, no difference in HIF1A mRNA levels was observed between cancerous and noncancerous tissue. Bisulfite DNA sequencing and high-resolution melting analysis identified significant DNA hypermethylation in the EPAS1 regulatory region from cancerous tissue compared with nonneoplastic tissue. Importantly, multivariate Cox regression analysis revealed a high HR for patients with cancer with low EPAS1 transcript levels (HR, 4.91; 95% confidence interval, CI, 0.42-56.15; P = 0.047) and hypermethylated EPAS1 DNA (HR, 33.94; 95% CI, 2.84-405.95; P = 0.0054). Treatment with a DNA methyltransferase inhibitor, 5-Aza-2'-deoxycytidine (5-aza-dC/Decitabine), upregulated EPAS1 expression in hypoxic colorectal cancer cells that were associated with DNA demethylation of the EPAS1 regulatory region. In summary, EPAS1 is transcriptionally regulated by DNA methylation in colorectal cancer. IMPLICATIONS: DNA methylation and mRNA status of EPAS1 have novel prognostic potential for colorectal cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825851     DOI: 10.1158/1541-7786.MCR-14-0054

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  23 in total

1.  LINE-1 and EPAS1 DNA methylation associations with high-altitude exposure.

Authors:  Ainash Childebayeva; Tamara R Jones; Jaclyn M Goodrich; Fabiola Leon-Velarde; Maria Rivera-Chira; Melisa Kiyamu; Tom D Brutsaert; Dana C Dolinoy; Abigail W Bigham
Journal:  Epigenetics       Date:  2019-01-09       Impact factor: 4.528

2.  Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression.

Authors:  Isabelle Westerlund; Yao Shi; Konstantinos Toskas; Stuart M Fell; Shuijie Li; Olga Surova; Erik Södersten; Per Kogner; Ulrika Nyman; Susanne Schlisio; Johan Holmberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

3.  EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial-mesenchymal transition.

Authors:  Qiang Zhen; Yaxiao Zhang; Lina Gao; Renfeng Wang; Weiwei Chu; Xiaojian Zhao; Zhe Li; Huixian Li; Bing Zhang; Baolei Lv; Jiabao Liu
Journal:  Strahlenther Onkol       Date:  2020-07-17       Impact factor: 3.621

Review 4.  The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.

Authors:  Joaquín Araos; Jonathan P Sleeman; Boyan K Garvalov
Journal:  Clin Exp Metastasis       Date:  2018-08-31       Impact factor: 5.150

Review 5.  Oxygen sensing in intestinal mucosal inflammation.

Authors:  Katharina Flück; Joachim Fandrey
Journal:  Pflugers Arch       Date:  2015-07-25       Impact factor: 3.657

6.  Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.

Authors:  Joo-Yun Byun; Kun Huang; Jong Suk Lee; Wenjie Huang; Li Hu; Xuyu Zheng; Xin Tang; Fengzeng Li; Dong-Gyu Jo; Xinmao Song; Chuang Huang
Journal:  Oncogene       Date:  2022-01-10       Impact factor: 8.756

7.  MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.

Authors:  Jie Cui; Biao Duan; Xuyang Zhao; Yan Chen; Shixun Sun; Wenjie Deng; Yujie Zhang; Jun Du; Yongchang Chen; Luo Gu
Journal:  Tumour Biol       Date:  2016-07-27

Review 8.  Role of Intestinal HIF-2α in Health and Disease.

Authors:  Sadeesh K Ramakrishnan; Yatrik M Shah
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

9.  Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.

Authors:  Agnieszka Anna Rawłuszko-Wieczorek; Agnieszka Siera; Karolina Horbacka; Nikodem Horst; Piotr Krokowicz; Paweł Piotr Jagodziński
Journal:  J Cancer Res Clin Oncol       Date:  2015-01-04       Impact factor: 4.553

10.  The Effects of 5-Aza-2'-Deoxycytidine and Valproic Acid on Apoptosis Induction and Cell Growth Inhibition in Colon Cancer HT 29 Cell Line.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi; Hamed Sahraeian
Journal:  Int J Prev Med       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.